Combination of organic compounds
Details for Australian Patent Application No. 2003240261 (hide)
International Classifications
Event Publications
11 September 2003 Complete Application Filed
Priority application(s): 60/381,547 17.05.02 US
29 January 2004 Application Open to Public Inspection
Published as AU-B-2003240261
28 June 2007 Application Accepted
Published as AU-B-2003240261
25 October 2007 Standard Patent Sealed
28 October 2010 Extension of Term of Standard Patents
Novartis AG The earliest first regulatory approval date provided by the patentee 09 Apr 2010 For the goods EXFORGE HCT
23 December 2010 Extension of Term of Standard Patents
Novartis AG The earliest first regulatory approval date provided by the patentee 09 Apr 2010 For the goods EXFORGE HCT Address for service in Australia: Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000
14 July 2011 Extension granted
Novartis AG The earliest first regulatory approval date provided by the patentee 09 Apr 2010 For the goods EXFORGE HCT Extension of Term of patent pursuant to Section 77 expires on 09 Apr 2025
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003240262-POLYMORPHISM OF SOATI USEFUL FOR IDENTIFYING RISK OF DEVELOPING ALZHEIMER'S DISEASE
2003240260-Method and reagent system having a non-regenerative enzyme-coenzyme complex
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser